当前位置:
首页>产品中心>单抗/多抗>Anti-Ipilimumab Polyclonal Antibody|抗伊匹木单抗多克隆抗体(靶标:伊匹木单抗(抗CTLA-4单抗))
Anti-Ipilimumab Polyclonal Antibody|抗伊匹木单抗多克隆抗体(靶标:伊匹木单抗(抗CTLA-4单抗))
- 货号:RB9TAB651014
- 价格:面议
- 点击:294
产品介绍
产品参数
| 形态 | Liquid |
|---|
| 宿主种属 | Rabbit |
|---|
| 克隆性 | Polyclonal |
|---|
| 抗体亚型 | IgG |
|---|
| 纯化方式 | Purified by antigen affinity column. |
|---|
| 内毒素水平 | Please contact with the lab for this information. |
|---|
| 应用 | ELISA |
|---|
| 特异性 | The product is specific for Ipilimumab. This antibody serves as an excellent positive control for Ipilimumab immunogenicity (ADA) assays. |
|---|
| 靶标 | Rabbit polyclonal to Yervoy. |
|---|
| 免疫原 | Ipilimumab |
|---|
| 储存缓冲液 | 0.01M PBS, pH 7.4. |
|---|
| 稳定性和储存 | The product can be stored for 2 - 3 weeks at 2 to 8°C or for up to 12 months at -20°C. Avoid repeated freezing and thawing cycles. |
|---|
| 产品使用说明 | ELISA:1:5000-1:20000;IHC:1:50-1:500;WB:1:500-1:2000 |
|---|
| 登录号 | CAS: 477202-00-9 |
|---|
| 背景信息 | Ipilimumab (Yervoy) is a humanized monoclonal antibody that is approved by the U.S. Food and Drug Administration for the treatment of patients with unresectable or metastatic melanoma. Ipilimumab works to activate the immune system by targeting CTLA-4 (Cytotoxic T-lymphocyte protein 4), a negative regulator of cytotoxic T-lymphocyte activity. Ipilimumab binds to CTLA-4, blocking the inhibitory signal, which allows the cytotoxic T-lymphocytes to destroy the cancer cells.
|
|---|
| 备注 | For research use only. |
|---|
【仅供科学研究使用】
相关产品: